avapro and trandolapril
avapro has been researched along with trandolapril in 9 studies
Research
Studies (9)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (66.67) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Abbenante, G; Fairlie, DP; Leung, D | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Barletta, G; Foschi, M; Franchi, F; Lazzeri, C; Tosti-Guerra, C | 1 |
Bernadet-Monrozies, P; Durand, D; Kamar, N; Rostaing, L | 1 |
Angermann, CE; Bauersachs, J; Behr, TM; Ertl, G; Fraccarollo, D; Frantz, S; Jung, P; Wagner, H | 1 |
Bauersachs, J; Ertl, G; Fraccarollo, D; Schäfer, A; Schmidt, I; Tas, P | 1 |
Reviews
3 review(s) available for avapro and trandolapril
Article | Year |
---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Endothelins; Hemodynamics; Humans; Hypertension; Indoles; Irbesartan; Kidney; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Verapamil | 2002 |
Trials
1 trial(s) available for avapro and trandolapril
Article | Year |
---|---|
Cardiac autonomic tone during trandolapril-irbesartan low-dose combined therapy in hypertension: a pilot project.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Autonomic Nervous System; Biphenyl Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Indoles; Irbesartan; Male; Middle Aged; Pilot Projects; Tetrazoles | 2002 |
Other Studies
5 other study(ies) available for avapro and trandolapril
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Heart Failure; Humans; Indoles; Interleukin-1; Irbesartan; Male; Myocardial Infarction; NF-kappa B; Rats; Rats, Wistar; Tetrazoles; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2003 |
Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism.
Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Biphenyl Compounds; Endothelium, Vascular; Heart Failure; Indoles; Irbesartan; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Random Allocation; Rats; Rats, Wistar; Superoxides; Tetrazoles; Treatment Outcome; Vasodilation | 2004 |